HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Tang Selected Research

Complement C5a (Complement 5a)

1/2020C5aR deficiency attenuates the breast cancer development via the p38/p21 axis.
1/2019C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
1/2018Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
12/2017C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Tang Research Topics

Disease

50Neoplasms (Cancer)
05/2022 - 01/2007
8Neoplasm Metastasis (Metastasis)
05/2022 - 11/2007
7Breast Neoplasms (Breast Cancer)
01/2022 - 01/2011
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 12/2018
6Infections
01/2021 - 07/2007
6Hypoxia (Hypoxemia)
01/2021 - 10/2004
6Stomach Neoplasms (Stomach Cancer)
01/2021 - 10/2013
6Genomic Instability
01/2021 - 02/2011
5Carcinogenesis
01/2022 - 01/2011
4Lung Neoplasms (Lung Cancer)
07/2022 - 01/2017
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 03/2019
4Melanoma (Melanoma, Malignant)
01/2021 - 01/2017
4Dehydration (Water Stress)
07/2017 - 02/2007
3Inflammation (Inflammations)
06/2022 - 11/2013
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2017
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2019
3Body Weight (Weight, Body)
09/2021 - 06/2006
3AIDS-Related Complex (ARC)
06/2021 - 01/2018
3Fibrosis (Cirrhosis)
11/2020 - 01/2018
3Ischemia
06/2018 - 02/2012
3Renal Cell Carcinoma (Grawitz Tumor)
10/2017 - 06/2015
3Nasopharyngeal Carcinoma
11/2007 - 07/2004
2Rectal Neoplasms (Rectal Cancer)
04/2022 - 01/2017
2Squamous Cell Carcinoma of Head and Neck
02/2022 - 01/2018
2Adenocarcinoma
01/2022 - 01/2021
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2016
2Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020 - 01/2018
2Hypersensitivity (Allergy)
01/2020 - 01/2016
2Reperfusion Injury
09/2019 - 06/2018
2Brain Ischemia (Cerebral Ischemia)
09/2019 - 06/2018
2Brain Edema (Cerebral Edema)
09/2019 - 06/2018
2Infarction (Infarctions)
09/2019 - 06/2018
2Hemorrhage
07/2018 - 04/2007
2Carcinoma (Carcinomatosis)
03/2017 - 11/2016
2Glioblastoma (Glioblastoma Multiforme)
12/2015 - 06/2015
2Diabetes Mellitus
11/2014 - 10/2013
2Rupture
09/2013 - 11/2011
1Wound Infection (Wound Infections)
07/2022
1Radiation Pneumonitis
07/2022
1Wounds and Injuries (Trauma)
07/2022
1Ankle Injuries (Ankle Injury)
07/2022
1Colitis
06/2022

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
10/2021 - 07/2004
10ChromatinIBA
01/2022 - 09/2013
9Biomarkers (Surrogate Marker)IBA
02/2022 - 03/2015
6Histones (Histone)IBA
01/2022 - 09/2013
4CytokinesIBA
07/2022 - 01/2019
4Biological ProductsIBA
07/2022 - 11/2007
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 06/2015
4Deubiquitinating EnzymesIBA
11/2021 - 01/2019
4Pharmaceutical PreparationsIBA
01/2021 - 01/2017
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2011
4Complement C5a (Complement 5a)IBA
01/2020 - 12/2017
3EnzymesIBA
07/2022 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
3TrehaloseIBA
09/2021 - 02/2007
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 07/2014
3Transcription Factors (Transcription Factor)IBA
01/2021 - 11/2007
2MicroRNAs (MicroRNA)IBA
07/2022 - 01/2011
2Sucrose (Saccharose)IBA
06/2022 - 07/2015
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2022 - 01/2022
2Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 11/2021
2GlycogenIBA
09/2021 - 01/2021
2Nonesterified Fatty Acids (NEFA)IBA
09/2021 - 01/2021
2Urea (Carbamide)FDA LinkGeneric
08/2021 - 09/2013
2Therapeutic UsesIBA
08/2021 - 01/2017
2Lysine (L-Lysine)FDA Link
01/2021 - 01/2018
2Histone MethyltransferasesIBA
10/2020 - 01/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2020 - 01/2019
2Oxygen (Dioxygen)IBA
04/2020 - 01/2018
2Neuroprotective AgentsIBA
09/2019 - 06/2018
2hispidulinIBA
09/2019 - 06/2018
2NAD (NADH)IBA
11/2017 - 01/2017
2Cadherins (E-Cadherin)IBA
11/2016 - 09/2014
2icaritinIBA
12/2015 - 06/2015
2LipidsIBA
07/2015 - 02/2007
2SolutionsIBA
11/2011 - 10/2004
2Peptides (Polypeptides)IBA
01/2008 - 06/2006
2Tetracycline (Achromycin)FDA LinkGeneric
08/2004 - 07/2004
1ImmunosorbentsIBA
07/2022
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
06/2022
116S Ribosomal RNAIBA
06/2022
1CarbohydratesIBA
06/2022
1OligosaccharidesIBA
06/2022
1Dextrans (Dextran)FDA Link
06/2022
1RaffinoseIBA
06/2022
1Anti-Bacterial Agents (Antibiotics)IBA
06/2022

Therapy/Procedure

16Therapeutics
05/2022 - 01/2013
6Radiotherapy
07/2022 - 01/2017
5Gastrectomy
07/2018 - 10/2013
4Immunotherapy
01/2022 - 01/2021
3Drug Therapy (Chemotherapy)
04/2022 - 01/2019
3Transplantation
11/2016 - 07/2010
2Photochemotherapy (Photodynamic Therapy)
04/2020 - 01/2019
2Critical Care (Surgical Intensive Care)
07/2018 - 11/2014
2Length of Stay
11/2014 - 10/2013
2Aftercare (After-Treatment)
08/2014 - 01/2013
1Reoperation
07/2022
1Sutures (Suture)
07/2022
1Oral Administration
06/2022